BeOne Medicines (ONC) Net Cash Flow (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.84% |
| Dec 31, 2025 | -63.79% |
| Sep 30, 2025 | 466.57% |
| Jun 30, 2025 | 307.83% |
| Mar 31, 2025 | -386.05% |
| Dec 31, 2024 | -134.20% |
| Sep 30, 2024 | 136.57% |
| Jun 30, 2024 | 48.44% |
| Mar 31, 2024 | -666.82% |
| Dec 31, 2023 | 118.41% |
| Sep 30, 2023 | -468.60% |
| Jun 30, 2023 | 82.48% |
| Mar 31, 2023 | 12.16% |
| Dec 31, 2022 | -43.30% |
| Sep 30, 2022 | -204.22% |
| Jun 30, 2022 | 797.63% |
| Mar 31, 2022 | -101.10% |
| Dec 31, 2021 | 950.66% |
| Sep 30, 2021 | -199.54% |
| Jun 30, 2021 | -125.37% |
| Mar 31, 2021 | 660.32% |
| Dec 31, 2020 | -184.18% |
| Sep 30, 2020 | 118.17% |
| Jun 30, 2020 | -145.48% |
| Mar 31, 2020 | 565.69% |
| Dec 31, 2019 | -1,000.64% |
| Sep 30, 2019 | -116.27% |
| Jun 30, 2019 | 271.59% |
| Mar 31, 2019 | 54.18% |
| Dec 31, 2018 | -88.67% |
| Sep 30, 2018 | 782.09% |
| Jun 30, 2018 | -113.74% |
| Mar 31, 2018 | 828.20% |
| Dec 31, 2017 | 151.90% |
| Sep 30, 2017 | -133.78% |
| Jun 30, 2017 | 1,471.51% |
| Mar 31, 2017 | 465.47% |
| Dec 31, 2016 | -93.32% |
| Sep 30, 2016 | 118.26% |
| Jun 30, 2016 | -178.87% |
| Mar 31, 2016 | 2,089.26% |
| Dec 31, 2015 | -448.83% |
| Sep 30, 2015 | 103.22% |
| Jun 30, 2015 | -17,646.67% |